Fig. 3From: Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRISeparate presentation of gross tumor volume changes during RCT relative to the first fraction of treatment for each patient (based on T2w sequence). While in the first 2 weeks all patients exhibited substantial tumor shrinkage, distinct differences were evident between pathological complete and partial responders (pCR and pPR) in the further course of RCTBack to article page